Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297037 · ClinicalTrials.gov registry record · Phase 2
Pimecrolimus Cream for Oral Lichen Planus
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT00297037: Completed Phase 2 study, sponsored by University of Utah.
NCT00297037 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 21 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00297037, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
Study investigating the use of pimecrolimus 1% cream for oral lichen planus
Primary Outcome
The primary efficacy variable was the change in the Investigator's Global Assessment of the overall severity of disease from baseline to week 6. Scale is 0-4. 0 is no disease. 4 is worst disease. Minimum score is 0. Maximum score is 4. Measurments were completed day 0, week 1, week 2, week 4, and week 6. Scores are listed at baseline (day 0) and end of study (week 6).
Interventions
- DRUG Pimecrolimus 1% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
What the finished NCT00297037 record still lists
NCT00297037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Pimecrolimus 1% cream is the first listed.
NCT00297037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00297037 about?
NCT00297037 is a clinical study titled "Pimecrolimus Cream for Oral Lichen Planus". Study investigating the use of pimecrolimus 1% cream for oral lichen planus
What is the current status of trial NCT00297037?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2005-08. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00297037?
The interventions under investigation include: Pimecrolimus 1% cream (DRUG).
Who is sponsoring clinical trial NCT00297037?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00297037's enrollment target sits among peer trials
21 1794th of 2000 higher than 196 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia